Sophia Genetics CEO Ross Muken reports acquisition of $137,188 in common shares

SOPH•2026-11-09

SOPHiA Genetics CEO and director Ross Muken purchased 20,000 ordinary shares at $6.8594 per share, bringing his direct beneficial ownership to 680,391 shares.

1. Share purchase

Ross Muken purchased 20,000 SOPHiA Genetics ordinary shares at $6.8594 per share. His direct beneficial ownership rose to 680,391 ordinary shares.

Sources

Sophia Genetics CEO Ross Muken reports acquisition of $137,188 in common shares

Sec

Sophia Genetics CEO Ross Muken reports acquisition of $137,188 in common shares

1. Share purchase

Related News

Shentel participates in six investor conferences

American Financial Group CFO Brian S. Hertzman sells 301 shares worth $46,744

Teladoc Health president Carlos Nueno reports sale of $270,774.40 in shares

Sources

Sophia Genetics CEO Ross Muken reports acquisition of $137,188 in common shares

Kochav Defense Acquisition announces extraordinary general meeting of shareholders

Third Coast Bank names Laura Rau chief risk officer